SPY310.52+2.16 0.70%
DIA257.31-0.56 -0.22%
IXIC10,154.63+95.86 0.95%

B. Riley FBR Downgrades Acasti Pharma to Neutral, Announces $2 Price Target

B. Riley FBR downgrades Acasti Pharma (NASDAQ:ACST) from Buy to Neutral and announces $2 price target.

Benzinga · -

B. Riley FBR downgrades Acasti Pharma (NASDAQ:ACST) from Buy to Neutral and announces $2 price target.